Anal câncer impact among people with HIV infection-a matched cohort study (2025)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.3332/ecancer.2025.1922
- Subjects: HIV; DOENÇAS DO ÂNUS; NEOPLASIAS COLORRETAIS
- Language: Inglês
- Objetivos de Desenvolvimento Sustentável (ODS):
03. Saúde e bem-estar
- Imprenta:
- Source:
- Título: Ecancermedicalscience
- ISSN: 1754-6605
- Volume/Número/Paginação/Ano: v. 19, article ID 1922, 11p, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ROBATTO, Amanda Acioli de Almeida et al. Anal câncer impact among people with HIV infection-a matched cohort study. Ecancermedicalscience, v. 19, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/87156. Acesso em: 08 fev. 2026. -
APA
Robatto, A. A. de A., Rocha, E. A., Bonadio, R. C., Galhera, D. A., Muratori, C. T., Bueno, A. A. B., et al. (2025). Anal câncer impact among people with HIV infection-a matched cohort study. Ecancermedicalscience, 19. doi:10.3332/ecancer.2025.1922 -
NLM
Robatto AA de A, Rocha EA, Bonadio RC, Galhera DA, Muratori CT, Bueno AAB, Dornellas AFL, Alban LBV, Victor CR, Hoff PMG. Anal câncer impact among people with HIV infection-a matched cohort study [Internet]. Ecancermedicalscience. 2025 ; 19[citado 2026 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87156 -
Vancouver
Robatto AA de A, Rocha EA, Bonadio RC, Galhera DA, Muratori CT, Bueno AAB, Dornellas AFL, Alban LBV, Victor CR, Hoff PMG. Anal câncer impact among people with HIV infection-a matched cohort study [Internet]. Ecancermedicalscience. 2025 ; 19[citado 2026 fev. 08 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87156 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre o DOI: 10.3332/ecancer.2025.1922 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
